
AGM/EGM3 Sept 2026, 05:11 pm
Senores Pharma Submits FY26 Annual Report and AGM Notice
AI Summary
Senores Pharmaceuticals Ltd has submitted its Annual Report for the financial year 2025-26, along with the notice for its Ninth Annual General Meeting (AGM). The AGM is scheduled for September 25, 2026, at 11:30 AM IST, to be conducted via Video Conferencing. The report includes the Business Responsibility and Sustainability Report. Members will receive the report electronically. Key dates for e-voting are September 18-24, 2026. The annual report details the company's corporate overview, management message, business segments, financials, and ESG commitment, highlighting a 'Positioned for the Next Leap' strategy focusing on organic growth and strategic acquisitions.
Key Highlights
- Annual Report for FY2025-26 submitted.
- Ninth AGM scheduled for September 25, 2026, via VC/OAVM.
- Includes Business Responsibility and Sustainability Report.
- Remote e-voting period from September 22-24, 2026.
- Company emphasizes organic growth and strategic acquisitions.
Price Impact
More from SENORES